Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net sales    
Total net sales $ 132,907 $ 155,300
Cost of sales    
Total cost of sales 73,037 78,843
Gross profit 59,870 76,457
Operating expenses    
Research and development, net 24,194 22,574
Selling, general and administrative 55,576 57,154
Total operating expenses 79,770 79,728
Operating income (loss) (19,900) (3,271)
Financial income (expense), net (829) 753
Income (loss) before income taxes (20,729) (2,518)
Income tax expenses 221 1,218
Share in profits (losses) of associated companies (838) 1,423
Net loss (21,788) (2,313)
Net loss attributable to non-controlling interests (85) (43)
Net loss attributable to Stratasys Ltd. $ (21,703) $ (2,270)
Net loss per ordinary share attributable to Stratasys Ltd. - basic and diluted $ (0.40) $ (0.04)
Weighted average ordinary shares outstanding. - basic and diluted 54,544 53,966
Comprehensive loss    
Net loss $ (21,788) $ (2,313)
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustments (1,954) (427)
Unrealized gains (losses) on derivatives designated as cash flow hedges 822 995
Other comprehensive income (loss), net of tax (1,132) 568
Comprehensive loss (22,920) (1,745)
Less: comprehensive loss attributable to non-controlling interests (85) (43)
Comprehensive loss attributable to Stratasys Ltd. (22,835) (1,702)
Products [Member]    
Net sales    
Total net sales 83,172 105,091
Cost of sales    
Total cost of sales 39,248 44,169
Services [Member]    
Net sales    
Total net sales 49,735 50,209
Cost of sales    
Total cost of sales $ 33,789 $ 34,674